Priority Date: 07.05.13 (GB 20130008137)

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS

  • Application ID: EP14726516
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
3 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 07.05.2013 - Priority Date (GB 20130008137)
  • 13.11.2014 - Publication A1 (WO2014180562)
  • 16.03.2016 - Publication A1 (EP2994463)
  • 25.10.2017 - Publication B1 (EP2994463)